Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid

Gastroenterology

Volumn 144, Issue 3, 2013, Pages 560-569.e7

  Carbone, Marco ^a   Mells, George F ^a   Pells, Greta ^b   Dawwas, Muhammad F ^a   Newton, Julia L ^c   Heneghan, Michael A ^d   Neuberger, James M ^e   Day, Darren B ^a   Ducker, Samantha J ^b   Sandford, Richard N ^a   Alexander, Graeme J ^a   Jones, David E J ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c and University of Bristol   (United Kingdom)

^d KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^e QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis Biliary; Liver Disease; Sex; Stratified Medicine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE SEVERITY; FATIGUE; FEMALE; FOLLOW UP; GENETIC SUSCEPTIBILITY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTOR VARIABLE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; SEX DIFFERENCE; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; UNITED KINGDOM;

EID: 84874043156     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.12.005     Document Type: Article

References (22)

1. A. Pares, L. Caballeria, J. Rodes Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid Gastroenterology 130 2006 715 720
2. C. Corpechot, O. Chazouilleres, R. Poupon Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome J Hepatol 55 2011 1361 1367
3. T. Kumagi, M. Guindi, S.E. Fisacher Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis Am J Gastroenterol 105 2010 2186 2194
4. D.E.J. Jones, K. Kowdley, R. Chapman The first new monotherapy therapeutic PBC study in a decade: an international study evaluating the farnesoid X receptor agonist obeticholic acid in PBC Gut 60 2011 A50
5. C. Levy, J.A. Peter, D.R. Nelson Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid Aliment Pharmacol Ther 33 2011 235 242
6. J. Goldblatt, P.J.S. Taylor, T. Lipman The true impact of fatigue in primary biliary cirrhosis: a population study Gastroenterology 122 2002 1235 1241
7. J.L. Newton, N. Bhala, J. Burt Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure J Hepatol 44 2006 776 782
8. J.V. Metcalf, O.F.W. James The geoepidemiology of primary biliary cirrhosis Semin Liver Dis 17 1996 13 22
9. L.R. Rubel, L. Rabin, L.B. Seeff Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women Hepatology 4 1984 671 677
10. G. Nalbandian, J. Van de Water, R. Gish Is there a serological difference between men and women with primary biliary cirrhosis Am J Gastroenterol 94 1999 2482 2486
11. E.M.M. Kuiper, B.E. Hansen, R.A. De Vries Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid Gastroenterology 136 2009 1281 1287
12. G.F. Mells, J.A.B. Floyd, K.I. Morley Genome-wide association study identifies 13 additional susceptibility loci for primary biliary cirrhosis Nat Genet 43 2011 329 332
13. C. Corpechot, L. Abenavoli, N. Rabahi Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis Hepatology 48 2008 871 877
14. A. Jacoby, A. Rannard, D. Buck Development, validation and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis Gut 54 2005 1622 1629
15. J.L. Newton, J.G. Gibson, M. Tomlinson Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence Hepatology 44 2006 91 98
16. J.L. Newton, M. Hudson, P. Tachtatzis The population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis Hepatology 45 2007 1496 1505
17. P. Blackburn, M. Freeston, C.R. Baker The role of psychological factors in the fatigue of primary biliary cirrhosis Liver Int 27 2007 654 661
18. J.L. Newton, J. Pairman, K. Sutcliffe A predictive model for fatigue and its aetiological associations in primary biliary cirrhosis Clin Gastroenterol Hepatol 6 2008 228 233
19. J.L. Newton, A. Davidson, S. Kerr Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity Eur J Gastroenterol Hepatol 19 2007 125 132
20. D. Alvaro, P. Invernizzi, P. Onori Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis J Hepatol 41 2004 905 912
21. P. Invernizzi, D. Alvaro, A. Crosignani Tamoxifen in treatment of primary biliary cirrhosis Hepatology 39 2004 1175 1176
22. A. Reddy, M. Prince, O.F.W. James Tamoxifen: a novel treatment for primary biliary cirrhosis? Liver Int 24 2004 194 197